|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0021469,
umls-concept:C0021853,
umls-concept:C0022686,
umls-concept:C0022688,
umls-concept:C0024299,
umls-concept:C0031437,
umls-concept:C0079772,
umls-concept:C0185117,
umls-concept:C0443288,
umls-concept:C0597357,
umls-concept:C1511636,
umls-concept:C1515021,
umls-concept:C2911684
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2001-3-16
|
|
pubmed:abstractText |
Killer inhibitory receptors (KIR) have a modulating effect on the cytotoxic functions of natural killer (NK) cells and T cells. Because lymphoma cells often have the same receptors as their non-neoplastic counterparts, this study investigated the expression of KIR on well defined groups of NK and T cell lymphomas, with and without a cytotoxic phenotype, from different sites of origin.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-10233858,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-10382762,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-10396241,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-10577857,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-10828054,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-1849153,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-2104899,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-2147946,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-2558138,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-7508176,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-7524749,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-7687640,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-7749980,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-8381831,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-8393921,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-8546210,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-8901599,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-8916967,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-9028330,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-9138008,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-9207472,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-9347791,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-9363445,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-9368779,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-9430220,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11253136-9560179
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD3,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD56,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Immunologic,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, KIR,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, KIR2DL1,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, KIR2DL3
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0021-9746
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
224-8
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:11253136-Antigens, CD3,
pubmed-meshheading:11253136-Antigens, CD56,
pubmed-meshheading:11253136-Humans,
pubmed-meshheading:11253136-Immunoenzyme Techniques,
pubmed-meshheading:11253136-Immunophenotyping,
pubmed-meshheading:11253136-Intestinal Neoplasms,
pubmed-meshheading:11253136-Killer Cells, Natural,
pubmed-meshheading:11253136-Lymphoma,
pubmed-meshheading:11253136-Lymphoma, T-Cell,
pubmed-meshheading:11253136-Nasopharyngeal Neoplasms,
pubmed-meshheading:11253136-Neoplasm Proteins,
pubmed-meshheading:11253136-Receptors, Immunologic,
pubmed-meshheading:11253136-Receptors, KIR,
pubmed-meshheading:11253136-Receptors, KIR2DL1,
pubmed-meshheading:11253136-Receptors, KIR2DL3,
pubmed-meshheading:11253136-Skin Neoplasms,
pubmed-meshheading:11253136-T-Lymphocytes, Cytotoxic
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype.
|
|
pubmed:affiliation |
Department of Pathology, Vrije Universiteit, Amsterdam, The Netherlands. d.dukers@azvu.nl
|
|
pubmed:publicationType |
Journal Article
|
